Patents by Inventor Maarten Groeneveld

Maarten Groeneveld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220153829
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 19, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Publication number: 20220153830
    Abstract: The present invention relates to methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNF antibody a recombinant anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 19, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Publication number: 20220144934
    Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
    Type: Application
    Filed: February 26, 2020
    Publication date: May 12, 2022
    Applicant: Janssen Biotech, Inc.
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith
  • Publication number: 20200291107
    Abstract: Methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, in CHO and specific pharmaceutical compositions of the antibody are useful in treating various diseases.
    Type: Application
    Filed: March 12, 2020
    Publication date: September 17, 2020
    Inventors: Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Michael Nedved, Kevin D. Smith